Insider Sentiment Summary: Drugs

Demo data is delayed six months. Subscribe today and get current information.  Learn More »
Report Time Period: 
Sentiment Summary

Last 52 Weeks

17-Oct-22 - 15-Oct-23
Buy Ratio:48%

Up

# Net Buyers:33
# Net Sellers:36

Previous 52 Weeks

18-Oct-21 - 16-Oct-22
Buy Ratio:29%
# Net Buyers:57
# Net Sellers:137
Buy Ratio History
Number of Companies Filing
Largest Positive Net Change
CompanyNet Buy AmountChange
Regeneron Pharmaceuticals, Inc.--$531.84M  
Catalent, Inc.--$391.39M  
Eli Lilly & Co--$335.42M  
Dicerna Pharmaceuticals Inc--$132.05M  
Seagen Inc.($797.75K)$95.49M  
New Net Buyers
CompanyNet Buy AmountChange
Abbvie Inc.$886.03K$65.28M  
Acadia Pharmaceuticals Inc$5.37M$5.58M  
Iveric Bio, Inc.$146.49K$3.61M  
Neurocrine Biosciences Inc$545.95K$3.29M  
Gilead Sciences, Inc.$1.18M$2.36M  
Largest Negative Net Change
CompanyNet Buy AmountChange
Incyte Corp$5.63M($112.99M)  
Armata Pharmaceuticals, Inc.--($49.00M)  
Horizon Therapeutics Public Ltd Co--($9.51M)  
Ani Pharmaceuticals Inc($9.21M)($9.39M)  
MacRogenics Inc--($3.70M)  
New Net Sellers
CompanyNet Buy AmountChange
Ani Pharmaceuticals Inc($9.21M)($9.39M)  
Galectin Therapeutics Inc($59.11K)($402.62K)